77 related articles for article (PubMed ID: 23653442)
1. Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor.
Eng H; Sharma R; McDonald TS; Edmonds DJ; Fortin JP; Li X; Stevens BD; Griffith DA; Limberakis C; Nolte WM; Price DA; Jackson M; Kalgutkar AS
Drug Metab Dispos; 2013 Aug; 41(8):1470-9. PubMed ID: 23653442
[TBL] [Abstract][Full Text] [Related]
2. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
Willard FS; Ho JD; Sloop KW
Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
[TBL] [Abstract][Full Text] [Related]
3. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.
Nolte WM; Fortin JP; Stevens BD; Aspnes GE; Griffith DA; Hoth LR; Ruggeri RB; Mathiowetz AM; Limberakis C; Hepworth D; Carpino PA
Nat Chem Biol; 2014 Aug; 10(8):629-31. PubMed ID: 24997604
[TBL] [Abstract][Full Text] [Related]
4. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
[TBL] [Abstract][Full Text] [Related]
5. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
Willard FS; Wootten D; Showalter AD; Savage EE; Ficorilli J; Farb TB; Bokvist K; Alsina-Fernandez J; Furness SG; Christopoulos A; Sexton PM; Sloop KW
Mol Pharmacol; 2012 Dec; 82(6):1066-73. PubMed ID: 22930710
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
[TBL] [Abstract][Full Text] [Related]
7. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
Cheong YH; Kim MK; Son MH; Kaang BK
Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
[TBL] [Abstract][Full Text] [Related]
8. Discovery of small molecule positive allosteric modulators of the secretin receptor.
Dengler DG; Harikumar KG; Pollari S; Sun Q; Brown BT; Shinoki-Iwaya A; Ardecky R; Miller LJ; Sergienko EA
Biochem Pharmacol; 2021 Mar; 185():114451. PubMed ID: 33545115
[TBL] [Abstract][Full Text] [Related]
9. Identifying glucagon-like peptide-1 mimetics using a novel functional reporter gene high-throughput screening assay.
Chen J; Bai G; Yang Y; Geng P; Cao Y; Zhu Y
Peptides; 2007 Apr; 28(4):928-34. PubMed ID: 17267075
[TBL] [Abstract][Full Text] [Related]
10. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic electrophilicity of a 4-substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine derivative: structural characterization of glutathione conjugates in vitro.
Kalgutkar AS; Mascitti V; Sharma R; Walker GW; Ryder T; McDonald TS; Chen Y; Preville C; Basak A; McClure KF; Kohrt JT; Robinson RP; Munchhof MJ; Cornelius P
Chem Res Toxicol; 2011 Feb; 24(2):269-78. PubMed ID: 21288051
[TBL] [Abstract][Full Text] [Related]
13. Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands.
Wootten D; Savage EE; Willard FS; Bueno AB; Sloop KW; Christopoulos A; Sexton PM
Mol Pharmacol; 2013 Apr; 83(4):822-34. PubMed ID: 23348499
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoids.
Wootten D; Simms J; Koole C; Woodman OL; Summers RJ; Christopoulos A; Sexton PM
J Pharmacol Exp Ther; 2011 Feb; 336(2):540-50. PubMed ID: 21075839
[TBL] [Abstract][Full Text] [Related]
15. A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.
Chen D; Liao J; Li N; Zhou C; Liu Q; Wang G; Zhang R; Zhang S; Lin L; Chen K; Xie X; Nan F; Young AA; Wang MW
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):943-8. PubMed ID: 17213311
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
During MJ; Cao L; Zuzga DS; Francis JS; Fitzsimons HL; Jiao X; Bland RJ; Klugmann M; Banks WA; Drucker DJ; Haile CN
Nat Med; 2003 Sep; 9(9):1173-9. PubMed ID: 12925848
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of endogenous metabolites as an avenue for drug discovery.
Wootten D; Savage EE; Valant C; May LT; Sloop KW; Ficorilli J; Showalter AD; Willard FS; Christopoulos A; Sexton PM
Mol Pharmacol; 2012 Aug; 82(2):281-90. PubMed ID: 22576254
[TBL] [Abstract][Full Text] [Related]
18. Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity.
Mapelli C; Natarajan SI; Meyer JP; Bastos MM; Bernatowicz MS; Lee VG; Pluscec J; Riexinger DJ; Sieber-McMaster ES; Constantine KL; Smith-Monroy CA; Golla R; Ma Z; Longhi DA; Shi D; Xin L; Taylor JR; Koplowitz B; Chi CL; Khanna A; Robinson GW; Seethala R; Antal-Zimanyi IA; Stoffel RH; Han S; Whaley JM; Huang CS; Krupinski J; Ewing WR
J Med Chem; 2009 Dec; 52(23):7788-99. PubMed ID: 19702274
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
Ma S; Subramanian R; Xu Y; Schrag M; Shou M
Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
[TBL] [Abstract][Full Text] [Related]
20. Approach for in vivo protein binding of 5-n-butyl-pyrazolo[1,5-a]pyrimidine bioactivated in chimeric mice with humanized liver by two-dimensional electrophoresis with accelerator mass spectrometry.
Yamazaki H; Kuribayashi S; Inoue T; Tateno C; Nishikura Y; Oofusa K; Harada D; Naito S; Horie T; Ohta S
Chem Res Toxicol; 2010 Jan; 23(1):152-8. PubMed ID: 19928966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
